Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...

This antifungal shampoo will be manufactured in Zydus Lifesciences’ topical manufacturing unit located at Changodar, ...

Zydus Lifesciences received approval from the USFDA to market Ketoconazole Shampoo, an antifungal medication, in the US. This ...

Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

Zydus Lifesciences receives USFDA approval to market Ketoconazole Shampoo, a generic antifungal medication for dandruff, ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Ketoconazole Shampoo is indicated for the treatment of dandruff, fungal infections and other skin conditions. It is an antifungal medication.

India's benchmark indexes Sensex and Nifty gained on Monday, following their largest increase in three months last week, ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...

On Monday, 1205 stocks advanced, 2878 declined and 146 remained unchanged on Bombay Stock Exchange with advance decline ratio ...